Undiagnosed Factor VII Deficiency in Cardiac Surgery Complicated by Bleeding: A Case Report.
Journal
A&A practice
ISSN: 2575-3126
Titre abrégé: A A Pract
Pays: United States
ID NLM: 101714112
Informations de publication
Date de publication:
01 Sep 2023
01 Sep 2023
Historique:
medline:
11
9
2023
pubmed:
8
9
2023
entrez:
8
9
2023
Statut:
epublish
Résumé
Rare bleeding disorders in the perioperative period call for targeted resuscitation strategies. Factor VII deficiency, for instance, is often corrected with exogenous administration of recombinant factor VIIa. This activated clotting factor, initially designed for patients with hemophilia A or B with factor inhibitors, is gaining popularity as a salvage therapy for severe and persistent traumatic and surgical bleeding. This article describes the management of a cardiothoracic surgical patient with undiagnosed isolated factor VII deficiency who experienced significant postoperative bleeding which subsided after the administration of recombinant factor VIIa. In this case, EXTEM failed to detect a clotting factor deficiency.
Identifiants
pubmed: 37681735
doi: 10.1213/XAA.0000000000001713
pii: 02054229-202309000-00001
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e01713Informations de copyright
Copyright © 2023 International Anesthesia Research Society.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Strauss ER, Mazzeffi MA, Williams B, Key NS, Tanaka KA. Perioperative management of rare coagulation factor deficiency states in cardiac surgery. Br J Anaesth. 2017;119:354–368.
Benlakhal F, Mura T, Schved JF, Giansily-Blaizot M; French Study Group of Factor VII Deficiency. French Study Group of Factor VII Deficiency. A retrospective analysis of 157 surgical procedures performed without replacement therapy in 83 unrelated factor VII-deficient patients. J Thromb Haemost. 2011;9:1149–1156.
Giansily-Blaizot M, Biron-Andreani C, Aguilar-Martinez P, et al. Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding. Br J Haematol. 2002;117:172–175.
Sevenet PO, Kaczor DA, Depasse F. Factor VII Deficiency: from basics to clinical laboratory diagnosis and patient management. Clin Appl Thromb Hemost. 2017;23:703–710.
Schulte S. Use of albumin fusion technology to prolong the half-life of recombinant factor VIIa. Thromb Res. 2008;122(suppl 4):S14–S19.
Mulliez SMN, Devreese KMJ. Isolated acquired factor VII deficiency: review of the literature. Acta Clin Belg. 2016;71:63–70.
Karkouti K, McCluskey SA, Syed S, Pazaratz C, Poonawala H, Crowther MA. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study. Anesth Analg. 2010;110:1533–1540.
Donahue BS, Gailani D, Mast AE. Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass. J Thromb Haemost. 2006;4:1011–1016.
Rosenthal C, Volk T, Spies C, Ziemer S, Holinski S, von Heymann C. Successful coronary artery bypass graft surgery in severe congenital factor VII deficiency: perioperative treatment with factor VII concentrate. Thromb Haemost. 2007;98:900–902.
Frattini F, Bonfanti C, Piccoli P, et al. Triple coronary artery bypass graft surgery in a patient with factor VII deficiency: a case report. Haemophilia. 2013;19:e268–e269.
Syburra T, Siciliano RD, Hofer C, Genoni M. Mitral valve surgery in severe congenital factor VII deficiency. Hematology. 2014;19:49–51.
Martin K, McMahon B. Successful coronary artery bypass grafting in a patient with severe FVII deficiency and minimal use of recombinant FVIIa. Haemophilia. 2014;20:e94–e97.
Kidd B, Sutherland L, Jabaley CS, Flynn B. Efficacy, safety, and strategies for recombinant-activated factor VII in cardiac surgical bleeding: a narrative review. J Cardiothorac Vasc Anesth. 2022;36:1157–1168.
Sutherland L, Houchin A, Wang T, et al. Impact of early, low-dose factor VIIa on subsequent transfusions and length of stay in cardiac surgery. J Cardiothorac Vasc Anesth. 2022;36:147–154.
Thomas GOR, Dutton RP, Hemlock B, et al. Thromboembolic complications associated with factor VIIa administration. J Trauma. 2007;62:564–569.